Evidence supporting a role for anti-Aβ antibodies in the treatment of Alzheimer’s disease
- 1 May 2004
- journal article
- editorial
- Published by Elsevier in Neurobiology of Aging
- Vol. 25 (5), 605-608
- https://doi.org/10.1016/j.neurobiolaging.2004.02.005
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloidInternational Immunology, 2003
- Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathologyProceedings of the National Academy of Sciences, 2003
- Short-term β-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP+PS1 mice.Behavioral Neuroscience, 2003
- Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-βIn Vivoby ImmunotherapyJournal of Neuroscience, 2002
- Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease modelNature Neuroscience, 2002
- Brain to Plasma Amyloid-β Efflux: a Measure of Brain Amyloid Burden in a Mouse Model of Alzheimer's DiseaseScience, 2002
- Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2001
- Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapyNature Medicine, 2001
- Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer diseaseNature Medicine, 2000
- N-terminal EFRH sequence of Alzheimer's β-amyloid peptide represents the epitope of its anti-aggregating antibodiesJournal of Neuroimmunology, 1998